Current issues with β2-adrenoceptor agonists -: Pharmacology and molecular and cellular mechanisms

被引:49
|
作者
Anderson, Gary P. [1 ]
机构
[1] Univ Melbourne, Dept Med & Pharmacol, Cooperat Res Ctr Chron Inflammatory Dis, Lung Dis Res Grp, Parkville, Vic 3052, Australia
关键词
beta(2)-adrenoreceptor; lung; tachyphylaxis; signal transduction; LABAs;
D O I
10.1385/CRIAI:31:2:119
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
beta(2)-Adrenoceptors are widely, almost ubiquitously, expressed. Activation of these receptors on bronchial smooth muscle by short- and long-acting beta(2)-adrenoceptor agonists causes bronchodilation. Here, the beta(2)-adrenoceptor is linked by the G protein, Gs, to adenylyl cyclase, which increases cyclic adenosine monophosphate (cAMP), thus activating protein kinase A, which affects calcium levels and reduces the efficiency of myosin light-chain kinase, causing relaxation. Activation also entrains numerous acute and longer term downregulation responses affecting the number, location, and net efficiency of signaling of the receptor. Synthetic beta(2)-agonists are all "partial agonists," incompletely able to optimally stimulate cAMP signal transduction. However, compared with some cells (such as mast cells) involved in exercise-induced asthma induction, airway smooth muscle is privileged in that transduction efficiency is intrinsically high and the tissue is very resistant to complete downregulation. Glucocorticosteroids have broadly beneficial interactions with beta(2)-adrenoceptors. Researchers have recently discovered that the beta(2)-adrenoceptor may function as a homodimer and that it can form heterodimers with both the beta(1)- and beta(3)-adrenoceptors, and possibly other receptors. This further complicates interpretation of the effect of beta(2)-adrenoceptor polymorphisms, but it is unknown whether this occurs in humans in vivo. Researchers have known for some time that strong contraction involving receptors coupled to the Gq G protein (e.g., cholinergic and leukotriene receptors via negative biochemical crosstalk), virus infection (via uncoupling), and inflammation (via kinases) can impair relaxation. Most recently, researchers have discovered that the beta(2)-adrenoceptor can also send potentially adverse signals after "atypical coupling" to Gq rather than Gs. The clinical implications of these uncouplings, crosstalk, and atypical coupling possibilities are not well-understood.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 50 条
  • [1] Current issues with β2-adrenoceptor agonistsPharmacology and molecular and cellular mechanisms
    Gary P. Anderson
    Clinical Reviews in Allergy & Immunology, 2006, 31 : 119 - 130
  • [2] Current issues with β2-adrenoceptor agonists -: Historical background
    Tattersfield, Anne E.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2006, 31 (2-3) : 107 - 117
  • [3] β2-adrenoceptor agonists: current and future direction
    Cazzola, Mario
    Calzetta, Luigino
    Matera, Maria Gabriella
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (01) : 4 - 17
  • [4] α2-Adrenoceptor agonists
    Sanders, Robert D.
    Maze, Mervyn
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (01) : 25 - 33
  • [5] Current issues with β2-adrenoceptor agonistsHistorical background
    Anne E. Tattersfield
    Clinical Reviews in Allergy & Immunology, 2006, 31 : 107 - 117
  • [6] α2-Adrenoceptor agonists as nasal decongestants
    Corboz, M. R.
    Mutter, J. C.
    Rivelli, M. A.
    Mingo, G. G.
    McLeod, R. L.
    Varty, L.
    Jia, Y.
    Cartwright, M.
    Hey, J. A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2007, 20 (02) : 149 - 156
  • [7] β-2-adrenoceptor agonists and nocturnal enuresis
    Meyboom, R. H. B.
    Pokladhikova, J.
    Ploen, M.
    DRUG SAFETY, 2006, 29 (10) : 928 - 928
  • [8] Mechanism of decongestant activity of α2-adrenoceptor agonists
    Corboz, M. R.
    Rivelli, M. A.
    Mingo, G. G.
    McLeod, R. L.
    Varty, L.
    Jia, Y.
    Hey, J. A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (03) : 449 - 454
  • [9] Paradoxical bronchoconstriction caused by β2-adrenoceptor agonists
    Ayed, Khadija
    Khalifa, Islam Latifa Hadj
    Mokaddem, Salma
    Jameleddine, Saloua Ben Khamsa
    DRUG TARGET INSIGHTS, 2020, 14 : 12 - 15
  • [10] A Selective Pharmacophore Model for β2-Adrenoceptor Agonists
    Xing, Rui-Juan
    Wang, Jian
    Pan, Li
    Cheng, Mao-Sheng
    MOLECULES, 2009, 14 (11) : 4486 - 4496